Is there a preferred triptan?

被引:18
作者
Dodick, DW
Silberstein, S
Dahlhöf, CGH
机构
[1] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA
[2] Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[3] Gothenburg Migraine Clin, S-41117 Gothenburg, Sweden
来源
HEADACHE | 2002年 / 42卷 / 01期
关键词
D O I
10.1046/j.1526-4610.2002.02001.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1 / 7
页数:7
相关论文
共 24 条
[21]   Ergotamine in the acute treatment of migraine -: A review and European consensus [J].
Tfelt-Hansen, P ;
Saxena, PR ;
Dahlöf, C ;
Pascual, J ;
Láinez, M ;
Henry, P ;
Diener, HC ;
Schoenen, J ;
Ferrari, MD ;
Goadsby, PJ .
BRAIN, 2000, 123 :9-18
[22]   Coronary side-effect potential of current and prospective antimigraine drugs [J].
VanDenBrink, AM ;
Reekers, M ;
Bax, WA ;
Ferrari, MD ;
Saxena, PR .
CIRCULATION, 1998, 98 (01) :25-30
[23]   Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients [J].
Visser, WH ;
Jaspers, NMWH ;
deVriend, RHM ;
Ferrari, MD .
CEPHALALGIA, 1996, 16 (04) :264-269
[24]   Tolerability of sumatriptan: clinical trials and post-marketing experience [J].
Welch, KMA ;
Mathew, NT ;
Stone, P ;
Rosamond, W ;
Saiers, J ;
Gutterman, D .
CEPHALALGIA, 2000, 20 (08) :687-695